Vaccine offers cervical cancer treatment hope

A new broad-spectrum vaccine could prove to be an effective treatment for cervical cancer, a new study has suggested.

Findings published in the Journal of the National Cancer Institute revealed that mice and rabbits immunised with a multimeric-L2 protein vaccine were protected from infection when exposed to human papillomavirus (HPV) type 16 some four months after being vaccinated.

The existing HPV L1-based vaccinations are nearly 100 per cent effective against the two main types of HPV, which between them account for 70 per cent of the world's cervical cancer cases.

But they are not able to provide the same level of protection against other cancer-causing HPV virus types.Concluding the study, the researchers wrote: "If an L2 vaccine were proven effective in people, its simpler manufacturing process could make the local production of such a vaccine highly feasible, which might achieve the goal of producing it at sustainable prices in emerging countries and lead to its widespread implementation in the developing world."

Cervical cancer can only be diagnosed through a biopsy of the cervix.

Comment on this page »


Latest news

Chelsea and Westminster named the best place to work in the NHS for 2015

Nuffield Health opens doors of new Cambridge Hospital

Nuffield Health plans to open state-of-the-art diagnostic suite

Vaccine offers cervical cancer treatment hope
Connect with us on:

This site compiles with the HONcode standard for trustworthy health information